"Could we see one day the stemcells being administered during a heart attack event to reduce bleeding and promote healing?"
Funny you should mention that! A few years back I remember MSB heavily promoting their trial in heart attacks (in Amsterdam, I think) - and now it's never mentioned. Wonder what happened there, they were well into recruitment as I recall.
Just reinforces the point @angelus512 made above about shifting the goalposts.
Bell Potter valuation, page-137
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.010(0.91%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.08 | $5.135M | 4.669M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 25747 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 4500 | 1 |
View Market Depth
| Last trade - 15.59pm 10/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |